101 related articles for article (PubMed ID: 19591997)
1. The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome.
Chen MJ; Chen HF; Chen SU; Ho HN; Yang YS; Yang WS
Fertil Steril; 2009 Dec; 92(6):2041-4. PubMed ID: 19591997
[TBL] [Abstract][Full Text] [Related]
2. Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
Chen MJ; Yang WS; Chen HF; Kuo JJ; Ho HN; Yang YS; Chen SU
Hum Reprod; 2010 Mar; 25(3):779-85. PubMed ID: 20093255
[TBL] [Abstract][Full Text] [Related]
3. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome.
Benson S; Janssen OE; Hahn S; Tan S; Dietz T; Mann K; Pleger K; Schedlowski M; Arck PC; Elsenbruch S
Brain Behav Immun; 2008 Feb; 22(2):177-84. PubMed ID: 17716857
[TBL] [Abstract][Full Text] [Related]
4. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
[TBL] [Abstract][Full Text] [Related]
5. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
Gen R; Akbay E; Muslu N; Sezer K; Cayan F
Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
7. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
[TBL] [Abstract][Full Text] [Related]
8. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
9. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
El-Mesallamy HO; Abd El-Razek RS; El-Refaie TA
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
Glintborg D; Højlund K; Andersen M; Henriksen JE; Beck-Nielsen H; Handberg A
Diabetes Care; 2008 Feb; 31(2):328-34. PubMed ID: 18000176
[TBL] [Abstract][Full Text] [Related]
11. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances.
Karadeniz M; Erdoğan M; Tamsel S; Zengi A; Alper GE; Cağlayan O; Saygili F; Yilmaz C
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):231-5. PubMed ID: 18393129
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome.
Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R
Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172
[TBL] [Abstract][Full Text] [Related]
14. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers.
Xita N; Papassotiriou I; Georgiou I; Vounatsou M; Margeli A; Tsatsoulis A
Metabolism; 2007 Jun; 56(6):766-71. PubMed ID: 17512308
[TBL] [Abstract][Full Text] [Related]
15. Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance.
Caglar GS; Oztas E; Karadag D; Pabuccu R; Demirtas S
Fertil Steril; 2011 Jan; 95(1):310-3. PubMed ID: 20701906
[TBL] [Abstract][Full Text] [Related]
16. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
17. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Endocrinol; 2006 Mar; 188(3):521-9. PubMed ID: 16522732
[TBL] [Abstract][Full Text] [Related]
18. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
Yang XF; Ren FR; Guo SP
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
20. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome.
Wu Y; Zhang J; Wen Y; Wang H; Zhang M; Cianflone K
Fertil Steril; 2009 Jan; 91(1):213-9. PubMed ID: 18206145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
